Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥374.8M | ¥316.2M | ¥290.2M | ¥328.8M | ¥357.3M | ¥471.6M | ¥906.5M | ¥714.1M | ¥284.7M | ¥70.3M |
| Gross profit | ¥251.9M | ¥209.0M | ¥199.3M | ¥225.8M | ¥264.9M | ¥206.2M | ¥256.9M | ¥197.1M | ¥71.3M | ¥22.6M |
| Research & development | ¥104.7M | ¥94.8M | ¥121.8M | ¥154.5M | ¥206.7M | ¥174.6M | ¥176.2M | ¥134.4M | ¥71.7M | ¥33.7M |
| Operating expenses | ¥253.9M | ¥225.2M | ¥250.2M | ¥358.2M | ¥403.1M | ¥396.0M | ¥404.1M | ¥289.9M | ¥163.8M | ¥80.3M |
| Operating income | ¥706,000 | −¥9.9M | −¥40.5M | −¥100.9M | −¥138.1M | −¥189.8M | −¥147.2M | −¥92.8M | −¥92.4M | −¥57.7M |
| EBITDAderived | ¥5.9M | −¥3.9M | −¥29.0M | −¥70.5M | −¥106.3M | −¥147.8M | −¥114.9M | −¥74.4M | −¥83.6M | −¥54.2M |
| Net income | ¥423,000 | −¥7.0M | −¥62.1M | −¥107.0M | −¥140.6M | −¥225.1M | −¥109.8M | −¥66.2M | −¥90.3M | −¥61.4M |
| Basic EPSper diluted share | — | — | — | — | — | — | — | — | -CN¥2.73 | -CN¥1.73 |
| Diluted EPSper diluted share | — | — | — | — | — | — | — | — | -CN¥2.73 | -CN¥1.73 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026Form 4 | Lee Hon SangDirector | SellAmerican depositary shares | 10.0K | $5.70 | $57.0K | 6.6K |
| Jun 1, 2026Form 4 | Lee Hon SangDirector | SellAmerican depositary shares | 182 | $5.95 | $1.1K | 16.6K |
| Mar 30, 2026Form 4 | Lee Hon SangDirector | SellAmerican depositary shares | 100 | $7.00 | $700.00 | 16.7K |
| Mar 25, 2026Form 4 | Lee Hon SangDirector | SellAmerican depositary shares | 1.5K | $7.00 | $10.2K | 16.8K |